Opportunity ID: 211773
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | NOT-FD-13-001 |
| Funding Opportunity Title: | Request for Information (RFI): MDEpiNET PPP |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Other |
| Category of Funding Activity: | Consumer Protection Health Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 11, 2013 Responses to this RFI are due January 11, 2013 by 11:59 PM Eastern Time. Responses must be submitted electronically to Lisa.Ko@fda.hhs.gov. |
| Current Closing Date for Applications: | Jan 11, 2013 Responses to this RFI are due January 11, 2013 by 11:59 PM Eastern Time. Responses must be submitted electronically to Lisa.Ko@fda.hhs.gov. |
| Archive Date: | Feb 10, 2013 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | FDA is interested in obtaining multi stakeholder input related to the operations of the MDEpiNet PPP, to ensure that it is developed in a way that supports not only FDA, but the missions of other participating partners, thus providing the maximum impact on public health. This RFI is focused on better understanding of capabilities and approaches for the management of the MDEpiNet PPP to support the national postmarket surveillance plan. Specifically, FDA requires input related to the following questions:
What role is envisioned for partners representing the patient, government, medical device industry, academia, health care providers, professional organizations, health care payer, and other sectors, and what are the parameters for their membership in the MDEpiNet PPP? Which additional partnership sectors should be represented, if any, and are there specific groups without whom the MDEpiNet PPP would not meet its mission? How would governance balance the desire for a comprehensive representative body against the need for nimble operations, usually accomplished through a small empowered team? What financial model(s) would best support the startup and sustained management of the PPP through the partnership management center? What are the ideal project proposal, selection, funding, and management models that would allow for appropriate buy-in and coordination, while allowing for scientific independence of investigators? What is the projected annual cost of operations, and what would be the ideal breakdown of federal and private funding to meet those needs? |
| Link to Additional Information: | Link to Full Announcement on NIH Guide for Contracts and Grants |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Lisa Ko
Grants Management Specialist Email:lisa.ko@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
Share This Post, Choose Your Platform!
About the Author: osnqt
